Health authorities in England are launching a vaccination campaign offering free meningitis B jabs to approximately one million young people. The initiative follows an outbreak in Kent documented as unprecedented and explosive, which resulted in 29 confirmed or suspected cases and two deaths within weeks earlier this year.
Eligibility for the free vaccine includes 17 and 18-year-olds in sixth form, as well as students under age 25 entering residential university or college settings for the first time this autumn. The vaccine is being administered as two doses, spaced at least 28 days apart, with nearly 90,000 doses already administered and 135,000 additional appointments scheduled for coming weeks. Vaccination can be accessed through high street pharmacies across England, with 17 and 18-year-olds able to book via the NHS National Booking Service if registered with a GP, while walk-in services are available for eligible individuals born on or after 21 July 2001.
Meningitis B poses significant health risks, potentially causing serious conditions including inflammation of the brain lining and blood poisoning. The infection can result in life-changing disabilities such as amputations, hearing loss, and brain damage, and can be fatal in some cases. Research indicates that students in their first year of university face a risk approximately seven times higher than similarly aged peers not attending university, attributed to increased social mixing and shared accommodation.
The meningitis B vaccine became part of the NHS childhood immunisation programme for babies born on or after 1 July 2015, meaning teenagers and young adults over age 11 have not previously received it through routine programmes. While vaccine experts suggest the government should consider routinely offering the vaccine to all teenagers around age 15, the current decision regarding broader implementation will rest with individual government ministers in each UK nation. Common side effects include injection site reactions and mild symptoms like fever or headache, typically resolving within one or two days, with serious adverse effects being rare.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI